KAYE MARK (EVP & CFO) sold 34.7% of their position (10.58K shares) of ELEVANCE HEALTH, INC. on the open market
Open‑market sale worth $4.66M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−400.00
Price / share
$434.00
Trade value
$173.60K
% of position
Common Stock
Shares
−321.00
Price / share
$435.25
Trade value
$139.72K
% of position
Common Stock
Shares
−1.66K
Price / share
$436.20
Trade value
$724.09K
% of position
Common Stock
Shares
−560.00
Price / share
$437.07
Trade value
$244.76K
% of position
Common Stock
Shares
−240.00
Price / share
$438.22
Trade value
$105.17K
% of position
Common Stock
Shares
−1.16K
Price / share
$439.25
Trade value
$509.53K
% of position
Common Stock
Shares
−1.72K
Price / share
$440.44
Trade value
$757.56K
% of position
Common Stock
Shares
−2.34K
Price / share
$441.34
Trade value
$1.03M
% of position
Common Stock
Shares
−480.00
Price / share
$442.61
Trade value
$212.45K
% of position
Common Stock
Shares
−440.00
Price / share
$443.81
Trade value
$195.28K
% of position
Common Stock
Shares
−160.00
Price / share
$444.85
Trade value
$71.18K
% of position
Common Stock
Shares
−827.00
Price / share
$446.05
Trade value
$368.88K
% of position
Common Stock
Shares
−273.00
Price / share
$447.19
Trade value
$122.08K
% of position
Net shares
−10.58K
Net value
-$4.66M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/22/2026 | S · Sale | −400.00 | $434.00 | $173.60K | 1.3% | 30.50K | 30.10K |
| Common Stock Direct | 10/22/2026 | S · Sale | −321.00 | $435.25 | $139.72K | 1.1% | 30.10K | 29.78K |
| Common Stock Direct | 10/22/2026 | S · Sale | −1.66K | $436.20 | $724.09K | 5.6% | 29.78K | 28.12K |
| Common Stock Direct | 10/22/2026 | S · Sale | −560.00 | $437.07 | $244.76K | 2.0% | 28.12K | 27.56K |
| Common Stock Direct | 10/22/2026 | S · Sale | −240.00 | $438.22 | $105.17K | 0.9% | 27.56K | 27.32K |
| Common Stock Direct | 10/22/2026 | S · Sale | −1.16K | $439.25 | $509.53K | 4.2% | 27.32K | 26.16K |
| Common Stock Direct | 10/22/2026 | S · Sale | −1.72K | $440.44 | $757.56K | 6.6% | 26.16K | 24.44K |
| Common Stock Direct | 10/22/2026 | S · Sale | −2.34K | $441.34 | $1.03M | 9.6% | 24.44K | 22.10K |
| Common Stock Direct | 10/22/2026 | S · Sale | −480.00 | $442.61 | $212.45K | 2.2% | 22.10K | 21.62K |
| Common Stock Direct | 10/22/2026 | S · Sale | −440.00 | $443.81 | $195.28K | 2.0% | 21.62K | 21.18K |
| Common Stock Direct | 10/22/2026 | S · Sale | −160.00 | $444.85 | $71.18K | 0.8% | 21.18K | 21.02K |
| Common Stock Direct | 10/22/2026 | S · Sale | −827.00 | $446.05 | $368.88K | 3.9% | 21.02K | 20.19K |
| Common Stock Direct | 10/22/2026 | S · Sale | −273.00 | $447.19 | $122.08K | 1.4% | 20.19K | 19.92K |
| Total | −10.58K | -$4.66M | ||||||